DNAYライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (4 1月 2023 @ 14:00):

Stats
本日の出来高	19 945
平均出来高	79 397
時価総額	38.32M
EPS	$-0.370 ( Q3 \| 2023-11-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0.130 (10.00%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-08-31	Kullback William J	Buy	300 000	Stock Option (right to buy)
2023-08-28	Kullback William J	Buy	0
2023-10-18	Herrema Gregory J.	Buy	229 787	Stock Option (right to buy)
2023-10-18	Herrema Gregory J.	Buy	153 191	Common Stock
2023-10-18	Herrema Gregory J.	Buy	0

INSIDER POWER
96.64
Last 81 transactions
Buy: 30 855 803 \| Sell: 22 356 163

ボリューム相関

長: 0.34 (neutral)

短: -0.56 (weak negative)

Signal:(51.007) Neutral

Codex DNA, Inc. 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Codex DNA, Inc. 相関 - 通貨/商品

0.60
( weak )

-0.60
( weak negative )

0.00
( neutral )

0.28
( neutral )

0.60
( weak )

-0.50
( weak negative )

Codex DNA, Inc. 財務諸表

Annual	2022
収益:	$27.44M
総利益:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2022
収益:	$27.44M
総利益:	$15.60M (56.84 %)
EPS:	$-1.640

FY	2021
収益:	$11.04M
総利益:	$4.30M (38.93 %)
EPS:	$-1.828

FY	2020
収益:	$6.58M
総利益:	$3.63M (55.12 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Codex DNA, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Codex DNA, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.